Skip to main content

Table 1 Baseline characteristics and summary statistics

From: Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)

 

Intervention

Control

Males n (%)

  

Females n (%)

  

Age median (IQRa)

  

Education < 10 years n (%)

  

Education 10–12 years n (%)

  

Education > 12 years n (%)

  

Homelessness n (%)

  

Social security benefits as income n (%)

  

Formal work as income n (%)

  

Methadone n (%)

  

Buprenorphine n (%)

  

Other opioid agonist treatment medications n (%)

  

Substance use last 30 days n (%)

  

Illicit opioids

  

Alcohol

  

Amphetamines or cocaine

  

Benzodiazepines

  

Cannabis

  

I.v. drug use last 6 months

  

Debut age smoking median (IQRa)

  

Years of smoking median (IQRa)

  

Average daily number of cigarettes smoked

  

Body mass index median (IQRa)

  

Obstructive pulmonary diseaseb n (%)

  
  1. aInter-quartile range
  2. bForced expiratory volume in the first second (FEV1)/forced vital capacity (FVC) ratio < 70% in spirometry